Hemostasis Diagnostics

Hemostasis Diagnostics Market is valued around USD 2228.8 Million in 2018 and expected to reach USD 3948.6 Million by 2025 with the CAGR of 8.1% over the forecast period. Increased prevalence of blood clotting disorders and increase in technological advancements are the key drivers for Global Hemostasis Diagnostics Market.

Hemostasis Diagnostics market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about hemostasis diagnostics market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with product type, test type, and end use.

Hemostasis diagnostics are those devices which help in the identification of hemostatic defects which leads to excessive bleeding. Hemostasis is a mechanism followed by the body after getting injured, it slows down the blood loss and stop the blood flow. This process is followed by three steps which include vasoconstriction, platelet plug formation and blood coagulation. Hemostasis helps in the diagnosis of actual cause of these disorders with history and helps in the treatment.

Hemostasis Diagnostics Analysis

There are various factors driving the growth of the hemostasis diagnostics market, one of the major factors driving the growth of the market is increased prevalence of blood clotting disorders such as hemophilia and others. As per Centers for Disease Control and Prevention report, Hemophilia A affects 1 in 5,000 male births and around 400 babies are born with hemophilia A each year. Furthermore, development of advanced diagnostic tools enables the healthcare professionals to detect the blood clotting factors and provide better treatment is also expected to fuel the growth of hemostasis diagnostics market over the forecast period. Moreover, increasing technological advancements for the development of advanced products for hemostasis diagnostics is also expected to support the growth of hemostasis diagnostics market over the forecast period.

Hemostasis Diagnostics Market ShareHemostasis Diagnostics Market Revenue (USD Million) Analysis by Regional and Global, 2021-2027

Global hemostasis diagnostics market report covers prominent players like Abbott Laboratories, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Thermo fisher Scientific Inc., Danaher Corporation, Sysmex Corporation, Siemens Healthineers, Alere Inc., Instrumentation Laboratory, Grifols S.A. and others.

Hemostasis Diagnostics Market Segmentation –
By Product Type 

Laboratory Systems
Consumables
Point-of-Care Testing Systems
By Test Type 

Prothrombin Time
Activated Partial Thromboplastin Time
Fibrinogen Degradation Products
Activated Clotting Time
Platelet Aggregation Test
D Dimer
By End User 

Hospital/Clinics
Independent Diagnostic
Laboratories
Other
By Region

North America
U.S.
Canada
Europe
UK
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
Mexico
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Hemostasis Diagnostics Market Key Players
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Nihon Kohden Corporation
Thermo fisher Scientific Inc.
Danaher Corporation
Sysmex Corporation
Siemens Healthineers
Alere Inc.
Instrumentation Laboratory
Grifols S.A.
Others

Interested in this report?

Get your sample now!

Download Sample